Amarin Corp Plc (AMRN)

[Durk 47]

Stay Long &Stay Strong! Here are the reasons why!

Baker Brothers & Amarin Mgt. are of the opinion Vascepa could be the best selling drug of all time- low cost, world wide market , once an MD prescribes, the patient will take for the rest of their lives. And unlike Lipitor,Vascepa has negligible side effects.

The $400M. Equity is to do the following: build inventory, possibly buy or build a mfg plant, add 400 sales reps and start a massive consumer advertising campaign . However, Amarin can not commence advertising until the FDA Office of Prescription Drug Promotion approves the advertising copy. This process takes 5-6 months after FDA approval.

With 800 reps and consumer advertising, Sales could easily reach $1B for 12/31/20 & $2B for 12/31/21 with European approval which will happen in the next 6-9 months . My sense a 25% chance of a buyout this fall under $35 and a 75% chance of a buyout within 2 years between $35-50. There were 3-4 biotech stocks , Array being one of them that were bought out within 120 days of a public offering. What I do not understand is why the stock price has not received more support from Goldman &JP Morgan. That is their job as underwriters and market makers!

Stay Long and Stay Strong, the Best is yet to Come!